v3.26.1
Summary of Significant Accounting Policies - Additional Information (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
Segment
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
$ / shares
Summary Of Significant Accounting Policies [Line Items]      
Cash, cash equivalents and restricted cash, maturity period three months or less    
Net loss $ (39,025) $ (6,495)  
Cash and cash equivalents and short-term investments 111,100    
Working capital 100,100    
Accumulated deficit $ (440,228)   $ (401,203)
Common stock, par value | $ / shares $ 0.001   $ 0.001
Going concern conditions or events description The Company expects that, based on its current operating plans, the Company’s existing cash, cash equivalents and marketable securities will be sufficient to fund its currently planned operations for at least the next 12 months from the filing date of these unaudited condensed consolidated financial statements. The Company anticipates it will require additional financing to fund its future operations. Even if the Company believes it has sufficient funds for its current or future operating plans, the Company may seek to raise additional capital if market conditions are favorable or in light of other strategic considerations.    
Recognized expense of employer contributions to the plan $ 100 $ 100  
Convertible preferred stock, par value | $ / shares $ 0.001    
Weighted-average common shares outstanding, basic | shares 112,424,211 77,126,763  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] srt:ChiefExecutiveOfficerMember    
Segment Reporting, Factors Used to Identify Entity's Reportable Segments The CODM manages and allocates resources to the operations of the Company on a total company basis. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions, therapeutic areas and research and development projects that are in line with the Company’s long-term company wide strategic goals.    
Number of operating segments | Segment 1    
Number of reportable segments | Segment 1    
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description the CODM uses consolidated net income (loss) for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. Operating expenses are used to monitor budget versus actual results.    
Pre-Funded Warrants [Member]      
Summary Of Significant Accounting Policies [Line Items]      
Weighted-average common shares outstanding, basic | shares 36,629,572 17,274,293  
Warrants exercise price | $ / shares $ 0.001    
Series X and Series X1 Non-voting Convertible Preferred Stock [Member]      
Summary Of Significant Accounting Policies [Line Items]      
Convertible preferred stock, par value | $ / shares $ 0.001    
Anelixis Therapeutics, LLC and Otic Pharma, Ltd.      
Summary Of Significant Accounting Policies [Line Items]      
Ownership interest percentage 100.00%    
Otic Pharma, Inc. [Member]      
Summary Of Significant Accounting Policies [Line Items]      
Ownership interest percentage 100.00%